11 results
Antiplatelet Medications - Summary Table

Aspirin - Inhibits cyclooxygenase, preventing formation of thromboxane A2
 • Acute coronary
- Inhibits cyclooxygenase ... in a-fib P2Y12 Inhibitors ... ticagrelor) - Inhibits ... , abciximab) - Inhibits ... #Table #Pharmacology
Summary of characteristics of Platelet Aggregation Inhibitors

#AntiPlatelet #Inhibitors #Pharmacology #Table #Overview #Interactions #Pharmacology #Cardiology
Summary of characteristics ... Platelet Aggregation Inhibitors ... #AntiPlatelet #Inhibitors ... #Pharmacology # ... Table #Overview
DPP-4 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
DPP-4 Inhibitors ... - Pharmacology ... Summary Mechanisms ... of Action: Inhibits ... featured #DPP4 #Inhibitors
Summary table of the mechanism of action, side effect and contraindications of commonly used anti-coagulation drugs.
Summary table of ... Selective factor Xa inhibitors ... thrombin (factor lla) inhibitors ... anticoagulation #pharmacology ... doac #comparison #table
Summary of Diuretic Agents 
Subclass, Drug, Mechanism of Action, Effects, Clinical Applications, Pharmacokinetics, Toxicities, Interaction
CARBONIC ANHYDRASE
Summary of Diuretic ... CARBONIC ANHYDRASE INHIBITORS ... others SGLT2 INHIBITORS ... #Medications #Pharmacology ... #summary #table
SGLT2 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
SGLT2 Inhibitors ... - Pharmacology ... Summary Mechanisms ... of Action: Inhibits ... featured #SGLT2 #Inhibitors
(DOAC interactions) Cancer-treatment specific inducers (↑) and inhibitors (↓)
of cytochrome p450 CYP3A4 and P-glycoprotein.

DOACs are substrates
inducers (↑) and inhibitors ... concentrations, and inhibitors ... by inducers or inhibitors ... Pglycoprotein #inducers #inhibitors ... #Pharmacology
Antibiotic classification refers to the categorization of antibiotics based on their chemical structure, mechanism of action,
wall synthesis inhibitors ... Protein synthesis inhibitors ... DNA synthesis inhibitors ... RNA synthesis inhibitors ... Metabolic inhibitors
Clinically Significant Cardiovascular Drug-Drug Interactions With OTC Supplements and Herbal Products
Angiotensin-Converting Enzyme Inhibitors (ACEIs)
 • Night-blooming
Angiotensin-Converting Enzyme Inhibitors ... alpha-blockers, leading ... Monoamine Oxidase Inhibitors ... supplementals #herbal #pharmacology ... #DDI #table #cardiology
Antiarrhythmics Pharmacology Summary
Cardiac Conduction Phases:
Phase 0 - Ventricular Depolarization:
 • Na+ channels open leading to a
Antiarrhythmics Pharmacology ... Summary Cardiac ... Blockers: • MOA: Inhibit ... Antiarrhythmics #Pharmacology ... Classification #Classes #pathophysiology